Homocysteine and its thiolactone may promote apoptotic events in blood platelets in vitro

References

• Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992; 200: 218–229
   PubMed Web of Science ®Google Scholar
• Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem 2000; 277: 30425–30428
   Google Scholar
• Jakubowski H. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease. Clin Chem Lab Med 2005; 43: 1011–1014
   PubMed Web of Science ®Google Scholar
• Jakubowski H. Mechanism of the condensation of homocysteine thiolactone with aldehydes. Chem Eur 2006; 12: 8039–8043
   PubMed Web of Science ®Google Scholar
• Chwatko G, Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal Biochem 2005; 337: 271–277
   PubMed Web of Science ®Google Scholar
• Chwatko G, Jakubowski H. Urinary extraction of homocysteine thiolactone in humans. Clin Chem 2005; 51: 408–415
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni K. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 2006; 43: 275–283
   PubMed Web of Science ®Google Scholar
• Perła-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids 2007; 32: 561–572
   PubMed Web of Science ®Google Scholar
• Jakubowski H, Fersht AR. Alternative pathway for editing noncognate amino acids by aminoacyl-tRNA synthases. Nucleic Acids Res 1981; 9: 3105–3117
   PubMedGoogle Scholar
• Jakubowski H. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med 2003; 41: 1462–1466
   PubMedGoogle Scholar
• Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell Mol Life 2004; 61: 470–487
   PubMed Web of Science ®Google Scholar
• Karolczak K, Olas B. Mechanism action of homocysteine and its thiolactone in haemostasis system. Physiol Res 2009; 58: 623–633
   PubMed Web of Science ®Google Scholar
• Olas B, Kedzierska M, Wachowicz B. Comparative studies on homocysteine and its metabolite – homocysteine thiolactone action in blood platelets in vitro. Platelets 2008; 19: 520–527
   PubMed Web of Science ®Google Scholar
• Olas B, Kolodziejczyk J, Kedzierska M, Rywaniak J, Wachowicz B. Modification of human blood platelet induced by homocysteine and its thiolactone in vitro. Thromb Res 2009; 124: 689–694
   PubMed Web of Science ®Google Scholar
• Glowacki R, Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 2004; 279: 10864–10871
   PubMed Web of Science ®Google Scholar
• Hubmacher D, Cirulis JT, Miao M, Keeley FW, Reinhardt DP. Functional consequences of homocysteinylation of the elastic fiber proteins fibrillin-1 and tropelastin. J Biol Chem 2010; 285: 1188–1198
   PubMed Web of Science ®Google Scholar
• Olas B, Kolodziejczyk J, Malinowska J. May modifications of human plasma proteins stimulated by homocysteine and its thiolactone induce changes of haemostatic function of plasma in vitro?. General Physiol Biophys 2010; 29: 186–193
   PubMedGoogle Scholar
• Sibrian-Vazquez M, Escobedo JO, Lim S, Samoei GK, Strongin RM. Homocystamides promote free-radical and oxidative damage to proteins. Proc Natl Acad Sci USA 2010; 107: 551–554
   PubMed Web of Science ®Google Scholar
• Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 2001; 68: 2799–2811
   PubMedGoogle Scholar
• Kerkeni M, Tnani M, Chuniaud L, Miled A, Maaroufi K, Trivin F. Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone. Mol Cell Biochem 2006; 291: 119–126
   PubMedGoogle Scholar
• Zbidi H, Redondo PC, Lopez J, Bartegi A, Salido G, Rosado JA. Homocysteine induces caspase activation by endoplasmic reticlum stress in platelets from type 2 diabetics and health donors. Thromb Haemost 2010; 103: 1022–1032
   PubMedGoogle Scholar
• Glowacki R, Wójcik K, Bald E. Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 2001; 914: 29–35
   PubMed Web of Science ®Google Scholar
• Bald E, Chwatko G, Glowacki R, Kusmierek K. Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 2004; 1032: 109–115
   PubMed Web of Science ®Google Scholar
• Walkowiak B, Kralisz U, Michalec L, Majewska L, Koziołkiewicz W, Ligocka A, Cierniewski CS. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 2000; 99: 495–502
   PubMed Web of Science ®Google Scholar
• Walkowiak B, Michalak E, Koziołkiewicz W, Cierniewski CS. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 1989; 56: 763–766
   PubMed Web of Science ®Google Scholar
• Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, Ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534–3541
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646
   PubMed Web of Science ®Google Scholar
• Van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infraction. Clin Chem 2006; 52: 57–64
   Google Scholar
• Vanags DM, Orrenius S, Aguilar-Santelies M. Alternations in Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis. Br J Haematol 1997; 99: 824–831
   PubMed Web of Science ®Google Scholar
• Li J, Xia Y, Bernito AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion 2000; 40: 1320–1329
   PubMed Web of Science ®Google Scholar
• Kuter DJ. Apoptosis in platelets during ex vivo storage. Vox Sang 2002; 83: 311–333
   PubMedGoogle Scholar
• Wolf BB, Golstein JC, Stennice HR, Beere H, Amarante-Mendes GP, Salvesan GS, Green DR. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94: 1683–1692
   PubMed Web of Science ®Google Scholar
• Shcherbina A, Remold-O’Donnell E. Role of caspases in a subset of human platelet activation responses. Blood 1999; 93: 4222–4231
   PubMed Web of Science ®Google Scholar
• Brown SB, Clarke MCH, Magowan L, Sanderson H, Savil J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase independent cell clearance program. J Biol Chem 2000; 275: 5987–5996
   PubMed Web of Science ®Google Scholar
• Wachowicz B, Rywaniak JZ, Nowak P. Apoptotic markers in human blood platelets treated with peroxynitrite. Platelets 2008; 19: 624–635
   PubMed Web of Science ®Google Scholar
• Plenchette S, Moutet M, Benguella M, N’Gondara JP, Guigner F, Coffee C, Corcos L, Bettaieb A, Solary E. Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion. Leukemia 2001; 15: 1572–1581
   PubMed Web of Science ®Google Scholar
• Leoncini G, Bruzzese D, Signorello MG. A role for PLCγ2 in platelet activation by homocysteine. J Cell Biochem 2007; 100: 1255–1265
   PubMed Web of Science ®Google Scholar
• Levrand S, Pacher P, Pesse B, Rolli J, Feihl F, Waeber B, Liaudet L. Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite. Biochem Biophys Res Com 2007; 359: 445–450
   PubMed Web of Science ®Google Scholar
• Bao XM, Wu CF, Lu GP. Atorvastatin inhibits homocysteine – induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin 2010; 210: 114–121
   Google Scholar
• Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998; 91: 484–490
   PubMed Web of Science ®Google Scholar
• Wachowicz B, Olas B, Zbikowska HM, Buczyński A. Generation of reactive oxygen species in blood platelets. Platelets 2002; 13: 175–182
   PubMed Web of Science ®Google Scholar
• Krotz F, Sohn HY, Pohl U. Reactive oxygen species, players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988–1996
   PubMed Web of Science ®Google Scholar
• Olas B, Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007; 23: 1–11
   Google Scholar
• Jahn B, Hansch GM. Oxygen radical generation in human platelets: Depence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol 1990; 93: 73–79
   PubMedGoogle Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good the bad, and ugly. Am J Physiol 1996; 271: 6C1424–6C1437
   Google Scholar
• Saluk-Juszczak J, Olas B, Nowak P, Kolodziejczyk J, Wachowicz B, Zgirski A. The effect of lipopolysaccharide from Proteus mirabilis on the level of the stable end metabolic products of nitric oxide in blood platelets. Curr Microbiol 2007; 54: 27–30
   PubMed Web of Science ®Google Scholar
• Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci 1990; 87: 5193–5197
   PubMed Web of Science ®Google Scholar
• Lufrano M, Balazy M. Interactions of peroxynitrite and other nitrating substances with human platelets: The role of glutathione and peroxynitrite permeability. Biochem Pharmacol 2003; 65: 515–523
   PubMed Web of Science ®Google Scholar
• Signorello MG, Viviani GL, Armani U, Cerone R, Minniti G, Piana A, Leoncini G. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 2007; 120: 607–613
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: Possible involvement of S-nitrosothiols. Biochim Biophys Acta 1980; 631: 221–231
   PubMed Web of Science ®Google Scholar
• Upchurch GRJ, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JFJ, Loscalzo J. Homocyst(e)ine decrease biovailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272: 17012–17017
   PubMed Web of Science ®Google Scholar
• Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, Martarelli D, Mazzanti L. Homocysteine-induced inhibition of nitric oxide production in platelets: A study on healthy and diabetic subjects. Diabetologia 2001; 44: 979–982
   PubMed Web of Science ®Google Scholar
• Leoncini G, Bruzzese D, Signorello MG. Activation of p38MAPKinase/cPLA2 pathway in homocysteine treated platelets. J Thromb Haemos 2006; 4: 209–216
   PubMed Web of Science ®Google Scholar
• McGarrigle SA, Walsh GM, O’Neill S, Moran N, Collins PB. Homocysteine and its thiolactone derivative promote activation of the platelet integrin αIIbβ3. 8th UK Platelet Meeting, Reading, 2006, 73.
   Google Scholar